Log in
Log in
E-mail
Password

Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
  1. Homepage
  2. Equities
  3. Canada
  4. Toronto Stock Exchange
  5. Canopy Growth Corporation
  6. News
  7. Summary
    WEED   CA1380351009

CANOPY GROWTH CORPORATION

(WEED)
  Report
Delayed Toronto Stock Exchange  -  05/26 02:05:31 pm EDT
6.960 CAD   +8.07%
05/25SECTOR UPDATE : Health Care Stocks End Near Unchanged
MT
05/25SECTOR UPDATE : Health Care
MT
05/25Nextleaf Solutions Receives Jamaican Patent for Foundational Extraction Process
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Alliance Global Adjusts Canopy Growth's Price Target to CA$11 From CA$18, Maintains Neutral Rating

01/07/2022 | 07:54am EDT
share with twitter
share with LinkedIn
share with facebook


© MT Newswires 2022
All news about CANOPY GROWTH CORPORATION
05/25SECTOR UPDATE : Health Care Stocks End Near Unchanged
MT
05/25SECTOR UPDATE : Health Care
MT
05/25Nextleaf Solutions Receives Jamaican Patent for Foundational Extraction Process
MT
05/25The Valens Company Climbs 9.5% as Canadian Recreational Market Share Expands in April
MT
05/25High Tide Gains Over 5% as Subsidiary Starts Discount Program in U.K. to Grow Recurring..
MT
05/25The Valens Company Says Expands Canadian Recreational Market Share in April; Stock Rise..
MT
05/25High Tide Subsidiary Blessed CBD Starts Discount Program in U.K. to Grow Recurring Reve..
MT
05/25Emyria Validates Safety of Cannabidiol Product from Phase 1 Study; Shares Sink 8%
MT
05/25Bod Australia Completes Proof of Concept Study for Cannabis Compound
MT
05/24Avicanna Subsidiary Completes First Commercial Export of Aureus-Branded THC and CBD Ext..
MT
More news
Analyst Recommendations on CANOPY GROWTH CORPORATION
More recommendations
Financials
Sales 2022 544 M 426 M 426 M
Net income 2022 100 M 78,4 M 78,4 M
Net Debt 2022 38,1 M 29,8 M 29,8 M
P/E ratio 2022 20,7x
Yield 2022 -
Capitalization 2 568 M 2 001 M 2 008 M
EV / Sales 2022 4,79x
EV / Sales 2023 4,85x
Nbr of Employees 3 259
Free-Float 63,8%
Chart CANOPY GROWTH CORPORATION
Duration : Period :
Canopy Growth Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CANOPY GROWTH CORPORATION
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus UNDERPERFORM
Number of Analysts 21
Last Close Price 6,44 CAD
Average target price 9,92 CAD
Spread / Average Target 54,1%
EPS Revisions
Managers and Directors
David Eric Klein Chief Executive Officer & Non-Independent Director
Judy Hong Chief Financial Officer & VP-Investor Relations
Judy A. Schmeling Chairman
Ru Wadasinghe Chief Information Officer
Mark A. Ware Chief Medical Officer
Sector and Competitors
1st jan.Capi. (M$)
CANOPY GROWTH CORPORATION-41.67%2 001
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.13.57%5 557
DONG-E-E-JIAO CO.,LTD.-36.57%2 976
TASLY PHARMACEUTICAL GROUP CO., LTD-34.70%2 311
PT INDUSTRI JAMU DAN FARMASI SIDO MUNCUL TBK10.98%1 968
GUIZHOU XINBANG PHARMACEUTICAL CO., LTD.-35.58%1 388